Viewing Study NCT07457918


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-04-06 @ 12:26 PM
Study NCT ID: NCT07457918
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-09
First Post: 2026-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Sponsor: Verrica Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module